• Busca personas
• Intranet

Neuroimagen de Enfermedades Neurodegenerativas y Envejecimiento Saludable Juan Domingo Gispert

Publicaciones 2024 (31)

• Shekari M, Vallez-Garcia D, Collij LE, Altomare D, Heeman F, Pemberton H, Roé-Vellvé N, Bullich S, Buckley C, Stephens A, Farrar G, Frisoni G, Klunk WE, Barkhof F, Gispert JD^*, ADNI and the AMYPAD consortium. Stress testing the Centiloid: Precision and variability of PET quantification of amyloid pathology. Alzheimers Dement 2024: (en Premsa).
• Fortea J^*, Vaqué-Alcazar L, Pegueroles J, Alcolea D, Belbin O, Dols Icardo O, Videla L, Gispert JD, Suarez-Calvet M, Johnson SC, Sperling R, Bejanin A, Lleó A, Montal V. Reply to: Challenges to identifying risk versus protective factors in Alzheimer's disease. Nat Med 2024: (en Premsa).
• Warmenhoven N, Sánchez-Benavides G, Gonzalez-Escalante A, Milà M, Shekari M, López D, Ortiz-Romero P, Kollmorgen G, Quijano-Rubio C, Minguillón C, Gispert JD, Vilor-Tejedor N, Arenaza-Urquijo EM, Palpatzis E, Ashton NJ, Zetterberg H, Blennow K, Suarez-Calvet M^*, Grau-Rivera O, ALFA Study. CSF glial biomarkers are associated with cognition in individuals at risk of Alzheimer's disease. Alzheimers Dement 2024: (en Premsa).
• Evans TE, Vilor N, Operto G, Falcon C, Hofman A, Ibañez A, Seshadari S, Tan LC, Weiner M, Alladi S, Anazodo U, Gispert JD, Adams HHH^*, Australian Imaging Biomarkers and Lifestyle flagship study of ageing. Structural brain differences in the Alzheimer's disease continuum: Insights into the heterogeneity from a large multi-site neuroimaging consortium. 2024: (en Premsa).
• Lorenzini L^*, Collij LE, Tesi N, Vilor-Tejedor N, Ingala S, Blennow K, Foley C, Frisoni GB, Haller S, Holstege H, van der van der Lee S, Martíne-Lage P, Marioni RE, Mccartney DL, O'Brien JT, Oliveira TG, Payoux P, Reinders M, Ritchie C, Scheltens P, Schwarz AJ, Sudre CH, Waldman AD, Wolz R, Chatelat G, Ewers M, Wink AM, Mutsaerts HJMM, Gispert JD, Visser PJ, Tijms BM, Altmann A, Barkhof F. Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non-demented individuals. Alzheimers Dement 2024: (en Premsa).
• Pujol J^*, Blanco-Hinojo L, Persavento C, Martínez-Vilavella G, Falcón C, Gascon M, Rivas I, Vilanova M, Deus J, Gispert JD, Gómez-Roig MD, Llurba E, Dadvand P, Sunyer J. Functional structure of local connections and differentiation of cerebral cortex areas in the neonate. Neuroimage 2024; 298: (en Premsa).
• Vila-Castelar C, Akinci M, Palpatzis E, Aguilar-Dominguez P, Operto G, Kollmorgen G, Quijano-Rubio C, Blennow K, Zetterberg H, Falcon C, Fauria K, Gispert JD, Grau-Rivera O, Suarez-Calvet M, Arenaza-Urquijo EM, ALFA study (...,Hernandez-Villamizar F, López D, Lugo F, Marne P, Menchon T, Minguillón C, Sánchez-Benavides G, Shekari M, Vilor N,...). Sex/gender effects of glial reactivity on preclinical Alzheimer's disease pathology. Mol Psychiatr 2024: (en Premsa).
• Pelkmans W, Gispert JD. Astroglial reactivity is a key modulator of Alzheimer's disease pathological progression. Brain 2024; 147: 3973-5 (en Premsa).
• Collij LE^*, Bollack A, La Joie R, Shekari M, Bullich S, Roé-Vellvé N, Koglin N, Jovalekic A, Vallez-Garcia D, Drzezga A, Garibotto V, Stephens AW, Battle M, Buckley C, Barkhof F, Farrar G, Gispert JD, AMYPAD consortium. Centiloid recommendations for clinical context-of-use from the AMYPAD consortium. Alzheimers Dement 2024: (en Premsa).
• Lorenzini L^*, Maranzano A, Ingala S, Collij LE, Tranfa M, Blennow K, Di Perri C, Foley C, Fox NC, Frisoni GB, Haller S, Martíne-Lage P, Mollison D, O'brien J, Payoux P, Ritchie C, Scheltens P, Schwarz AJ, Sudre CH, Tijms BM, Verde F, Ticozzi N, Silani V, Visser PJ, Waldman A, Wolz R, Chételat G, Ewers M, Wink AM, Mutsaerts H, Gispert JD, Wardlaw JM, Barkhof F. Association of Vascular Risk Factors and Cerebrovascular Pathology With Alzheimer Disease Pathologic Changes in Individuals Without Dementia. Neurology 2024; 103(7): e209801.
• Rodriguez-Fernandez B, Sánchez-Benavides G, Genius P, Minguillón C, Fauria K, de Vivo I, Navarro A, Molinuevo JL, Gispert JD, Sala-Vila A, Vilor-Tejedor N^*, Crous M^*, ALFA study. Association between telomere length and cognitive function among cognitively unimpaired individuals at risk of Alzheimer's disease. Neurobiol Aging 2024; 141: 140-150.
• Lázaro López I, Grau-Rivera O, Suarez-Calvet M, Fauria K, Minguillón C, Shekari M, Falcón C, García-Prat M, Huguet J, Molinuevo JL, Gispert JD^*, Sala-Vila A^*, ALFA study. Omega-3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer's disease dementia. Alzheimers Dement 2024; 16(3): e12596 (Acceptat).
• Ritchie C^*, Blennow K, Gispert JD, Johnson SC, van Maurik IS, Vermunt L, Suarez-Calvet M, Mchugh CP, Clement MHS, Anastasiu A, Rosenfeld E, Cosma O, Logan CA, Quevenco FC, Dias MC, Carboni M. NeuroToolKit Data Hackathon: advancing data collaboration in Alzheimer's disease. Front Neurosci . 2024; 18: 1339742 (Acceptat).
• Falcon C, Montesinos P, Václavu L, Kassinopoulos M, Minguillón C, Fauria K, Cascales D, Contador J, Fernández A, Navalpotro I, Puig-Pijoan A, Grau-Rivera O, Kollmorgen G, Quijano-Rubio C, Molinuevo JL, Zetterberg H, Blennow K, Suarez-Calvet M, Van Osch MJP, Sanchez-Gonzalez J, Gispert JD^*. Time-encoded ASL reveals lower cerebral blood flow in the early AD continuum. Alzheimers Dement 2024; 20(8): 5183-5197.
• López D, Suarez-Calvet M, Milà M, Gispert JD, Minguillón C, Quijano-Rubio C, Kollmorgen G, Zetterberg H, Blennow K, Grau-Rivera O^*, Sánchez-Benavides G^*. Awareness of episodic memory and meta-cognitive profiles: associations with cerebrospinal fluid biomarkers at the preclinical stage of the Alzheimer's continuum. Front Aging Neurosci . 2024; 16: 1394460 (Acceptat).
• Mastenbroek SE^*, Sala A, Vallez-Garcia D, Shekari M, Salvadó G, Lorenzini L, Pieperhoff L, Wink AM, Lopes I, Wolz R, Ritchie C, Boada M, Visser PJ, Bucci M, Farrar G, Hansson O, Nordberg AK, Ossenkoppele R, Barkhof F, Gispert JD, Rodríguez Vieitez E, Collij LE, Alzheimer's Disease Neuroimaging Initiative on behalf of the AMYPAD consortium. Continuous β-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity. Neurology 2024; 103(1): e209419.
• Quenon L^*, Collij LE, Vallez-Garcia D, Lopes I, Gérard T, Malotaux V, Huyghe L, Gispert JD, Jessen F, Visser PJ, den Braber A, Ritchie CW, Boada M, Marquié M, Vandenberghe R, Luckett ES, Schöll M, Frisoni GB, Buckley C, Stephens A, Altomare D, Ford L, Birck C, Mett A, Gismondi R, Wolz R, Grootoonk S, Manber R, Shekari M, Lhommel R, Dricot L, Ivanoiu A, Farrar G, Barkhof F, Hanseeuw BJ, AMYPAD Consortium. Amyloid-PET imaging predicts functional decline in clinically normal individuals. Alzheimers Res. Ther. 2024; 16(1): 130.
• Tranfa M^*, Lorenzini L, Collij LE, Vallez-Garcia D, Ingala S, Pontillo G, Pieperhoff L, Maranzano A, Wolz R, Haller S, Blennow K, Frisoni G, Sudre CH, Chételat G, Ewers M, Payoux P, Waldman A, Martíne-Lage P, Schwarz AJ, Ritchie CW, Wardlaw JM, Gispert JD, Brunetti A, Mutsaerts HJMM, Wink AM, Barkhof F. Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter Microstructure. Ann Clin Transl Neurol 2024; 11(6): 1541-1556.
• Palpatzis E, Akinci M, Aguilar-Dominguez P, García-Prat M, Blennow K, Zetterberg H, Carboni M, Kollmorgen G, Wild N, Fauria K^*, Falcón C, Gispert JD, Suarez-Calvet M, Grau-Rivera O, Sánchez-Benavides G, Arenaza-Urquijo EM^*, ALFA study. Lifetime Stressful Events Associated with Alzheimer's Pathologies, Neuroinflammation and Brain Structure in a Risk Enriched Cohort. Ann Neurol 2024; 95(6): 1058-1068.
• Fortea J^*, Pegueroles J, Alcolea D, Belbin O, Dols Icardo O, Vaqué-Alcazar L, Videla L, Gispert JD, Suarez-Calvet M, Johnson SC, Sperling R, Bejanin A, Lleó A, Montal V^*. APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease. Nat Med 2024; 30(5): 1284-1291.
• Bollack A^*, Collij LE, Vallez-Garcia D, Shekari M, Altomare D, Payoux P, Dubois B, Grau-Rivera O, Boada M, Marquié M, Nordberg A, Walker Z, Scheltens P, Schöll M, Wolz R, Schott JM, Gismondi R, Stephens A, Buckley C, Frisoni GB, Hanseeuw B, Visser PJ, Vandenberghe R, Drzezga A, Yaqub M, Boellaard R, Gispert JD, Markiewicz P, Cash DM, Farrar G, Barkhof F, AMYPAD consortium. Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study. Alzheimers Dement 2024; 20(5): 3429-3441.
• He R^*, Al-Tamimi J, Sánchez-Benavides G, Montaña-Valverde G, Gispert JD, Grau-Rivera O, Suarez-Calvet M, Minguillón C, Fauria K, Navarro A, Hinzen W. Atypical cortical hierarchy in A?-positive older adults and its reflection in spontaneous speech. Brain Res 2024; 1830: 148806.
• Mak E, Dounavi ME, Operto G, Ziukelis ET, Jones PS, Low A, Swann P, Newton C, Muniz-Terrera G, Malhotra P, Koychev I, Falcon C, Mackay C, Lawlor B, Naci L, Wells K, Ritchie C, Ritchie K, Su L, Gispert JD, O'Brien JT^*, PREVENT-Dementia and ALFA studies. APOE ?4 exacerbates age-dependent deficits in cortical microstructure. Brain Commun . 2024; 6(1): fcad351 (Acceptat).
• Shekari M. PET in preclinical AD: image harmonization, characterization of the centiloid metric of Aβ load and associations with tau fluid biomarkers. Universitat Pompeu Fabra. Director: Gispert JD. Fecha lectura: 16/04/2024.
  Cites:0
• Cumplido-Mayoral I, Brugulat-Serrat A, Sánchez-Benavides G, Gonzalez-Escalante A, Anastasi F, Milà M, López D, Akinci M, Falcon C, Shekari M, Cacciaglia R, Arenaza-Urquijo EM, Minguillón C, Fauria K, Molinuevo JL, Suarez-Calvet M, Grau-Rivera O, Vilaplana V, Gispert JD^*, ALFA study. The mediating role of neuroimaging-derived biological brain age in the association between risk factors for dementia and cognitive decline in middle-aged and older individuals without cognitive impairment: a cohort study. Lancet Healthy Longev . 2024; 5(4): e276-e286.
• Vilor-Tejedor N^*, Genius P, Rodriguez-Fernandez B, Minguillón C, Sadeghi I, Gonzalez-Escalante A, Crous M, Suarez-Calvet M, Grau-Rivera O, Brugulat-Serrat A, Sánchez-Benavides G, Esteller M, Fauria K, Molinuevo JL, Navarro A, Gispert JD^*, ALFA study. Genetic characterization of the ALFA study: Uncovering genetic profiles in the Alzheimer's continuum. Alzheimers Dement 2024; 20(3): 1703-1715.
• Solis-Urra P^*, Rodriguez-Ayllon M, Álvarez-Ortega M, Molina-Hidalgo C, Molina-Garcia P, Arroyo-Ávila C, García-Hermoso A, Collins AM, Jain S, Gispert JD, Liu-Ambrose T, Ortega FB, Erickson KI, Esteban-Cornejo I^*. Physical Performance and Amyloid-? in Humans: A Systematic Review and Meta-Analysis of Observational Studies. J Alzheimers Dis 2024; 96(4): 1427-1439.
• Young P, Heeman F, Axelsson J, Collij LE, Hitzel A, Sanaat A, Niñerola-Baizán A, Perissinotti A, Lubberink M, Frisoni GB, Zaidi H, Barkhof F, Farrar G, Baker S, Gispert JD, Garibotto V, Rieckmann A, Schöll M, AMYPAD consortium. Impact of simulated reduced injected dose on the assessment of amyloid PET scans. European Journal Of Nuclear Medicine And Molecular Imaging 2024; 51(3): 734-748.
• Gonzalez-Ortiz F^*, Ferreira PCL, Gonzalez-Escalante A, Montoliu-Gaya L, Ortiz-Romero P, Kac PR, Turton M, Kvartsberg H, Ashton NJ, Zetterberg H, Harrison P, Bellaver B, Povala G, Villemagne VL, Pascoal TA, Ganguli M, Cohen AD, Minguillón C, Contador J, Suarez-Calvet M, Karikari TK, Blennow K^*. A novel ultrasensitive assay for plasma p-tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's disease. Alzheimers Dement 2024; 20(2): 1239-1249.
• Pelkmans W^*, Shekari M, Brugulat-Serrat A, Sánchez-Benavides G, Minguillón C, Fauria K, Molinuevo JL, Grau-Rivera O, Gonzalez-Escalante A, Kollmorgen G, Carboni M, Ashton NJ, Zetterberg H, Blennow K, Suarez-Calvet M, Gispert JD^*, ALFA study. Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progression. Alzheimers Dement 2024; 20(1): 483-493.
• Sudre CH^*, VAN Wijnen, Dubost F, Adams H, Atkinson D, Barkhof F, Birhanu MA, Bron EE, Camarasa R, Chaturvedi N, Chen Y, Chen Z, Chen S, Dou Q, Evans T, Ezhov I, Gao H, Girones-Sanguesa M, Gispert JD, Gómez-Anson B, Hughes AD, Ikram MA, Ingala S, Jaeger HR, Kofler F, Kuijf HJ, Kutnar D, Lee M, Li B, Lorenzini L, Menze B, Molinuevo JL, Pan Y, Puybareau E, Rehwald R, SU R, Shi P, Smith L, Tillin T, Tochon G, Urien H, van der Velden BHM, van der Velpen IF, Wiestler B, Wolters FJ, Yilmaz P, de Groot M, Vernooij MW, de Bruijne M, ALFA study. Where is VALDO? VAscular Lesions Detection and segmentatiOn challenge at MICCAI 2021. Med Image Anal 2024; 91: 103029.